Vitamin D3 for Life

Live Enlightened

Article

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response: Full Study

Previous related pageSunscreen Use and Vitamin D SynthesisNext related pageVitamin D and Health
Study at a glance

Can signals about microbes activate vitamin D processes in immune cells?

This laboratory study used human immune cells called monocytes and macrophages. Researchers stimulated Toll-like receptors, structures that help these cells detect microbes. They investigated whether this stimulus activated vitamin D-related processes and helped the cells act against bacteria inside them. They also compared blood serum samples containing different amounts of vitamin D.

How did vitamin D-related activity change in the immune cells?

Stimulated cells increased the activity of genes involved in receiving vitamin D signals and changing vitamin D into its active form. These changes were linked to increased activity of the gene for cathelicidin, a substance that helps fight microbes, and to activity against bacteria. The findings supported vitamin D as part of this immune-cell response.

Did the vitamin D supply matter?

Serum containing less 25-hydroxyvitamin D, a form that cells can convert into active vitamin D, supported a weaker cathelicidin response. This linked the available vitamin D supply with activity inside the cells under the tested conditions. However, serum contains many substances, so differences between samples were not limited to vitamin D.

Does this cell study show that vitamin D supplements prevent infections?

The study did not test whether supplements prevent or treat infections in people. It did not show that all tissues respond in the same way or directly establish signals passing to neighbouring cells. Its findings concern a particular laboratory response. They do not prove that a blood vitamin D level alone determines protection against infection.

Read the full article below ↓

This page presents the full evidence record for this study. A concise overview is available on the Study Summary page.

Evidence from a single verified primary study evaluated using a fixed, auditable study-page structure.

Study classification and identity

Study type
Primary experimental human cellular / ex vivo study (human monocytes / macrophages), with functional readouts and serum-supported assays

Parent study or cohort
Not applicable

Ancillary analysis focus
Integration of endocrine substrate availability (circulating 25-hydroxyvitamin D) with induced local vitamin D activation and receptor-mediated signalling

Exposure type
Innate immune receptor activation (TLR triggering) with vitamin D pathway induction; serum 25-hydroxyvitamin D availability as a functional constraint on downstream signalling

Comparison or grouping structure
Stimulated vs unstimulated cells; functional comparisons across sera with differing 25-hydroxyvitamin D levels; mechanistic comparisons with pathway blockade / supplementation in assay context where applicable

Primary endpoint category
Local vitamin D pathway activation and downstream effector induction (gene expression and antimicrobial activity)

Clinical endpoints assessed
None (cellular / ex vivo mechanistic outcomes only)

Study purpose and framing

This study was conducted to clarify an important species-specific gap in how human innate immune cells execute antimicrobial responses after Toll-like receptor activation. Prior work in murine systems had placed nitric oxide as a dominant effector mechanism for macrophage antimicrobial activity, but human monocytes and macrophages do not mirror that pathway in the same way. The research problem therefore was not simply “does TLR activation kill pathogens,” but rather “what biological programme does TLR activation invoke in human macrophages to generate direct antimicrobial activity,” and what molecular signals bridge receptor triggering to functional killing of intracellular bacteria.

Within that framing, the investigators were testing whether vitamin D biology is not only present in immune contexts, but functionally required to complete a human macrophage antimicrobial response. The key idea is that vitamin D physiology is not limited to a single circulating hormone signal: circulating substrate availability can constrain local intracellular activation steps, and those local activation steps can be induced by a non-vitamin D stimulus (here, innate immune receptor engagement). That is an integration question because it links a systemic compartment (blood availability of 25-hydroxyvitamin D) to tissue-level signalling capacity (local conversion and receptor-mediated transcription) and finally to cell-level effector output (antimicrobial peptide induction and killing).

A further aim of the work was to show that variation in the endocrine pool of vitamin D metabolites has downstream consequences even when the “trigger” is entirely outside the vitamin D system. In other words, an innate immune stimulus can demand a vitamin D-mediated intracellular response, but the ability to execute that response may depend on whether the circulating substrate pool is sufficient to supply the local conversion step. The study therefore sits naturally under a whole-body physiology view of vitamin D, because it operationalises vitamin D as a distributed signalling system where systemic pools and local conversion are both required for full pathway expression.

Historically, vitamin D function was often conceptualised primarily as an endocrine hormone model: a circulating active metabolite acting on distant targets, with blood measurements treated as the dominant window into “vitamin D action.” That model persisted because endocrine physiology is comparatively accessible: blood can be sampled repeatedly, serum metabolite concentrations can be measured, and endocrine organs like the kidney are identifiable sites of production. By contrast, demonstrating local signalling in specific tissues or cell types requires direct access to those tissues, careful separation of systemic and local effects, and assays that can detect intracellular activation states rather than only circulating concentrations.

This study is unusual in its directness because it does not treat vitamin D signalling as a background endocrine state. Instead, it treats the vitamin D system as a programme that can be switched on locally by an external trigger, and then asks what happens downstream when systemic substrate supply is limiting. That approach implicitly challenges any single-compartment “serum-only” paradigm by showing that (a) local activation machinery can be induced, (b) receptor signalling can be functionally contingent on substrate availability, and (c) the relevant “vitamin D action” may be better conceptualised as an integrated chain from systemic pool to cellular conversion to receptor-mediated transcription rather than as a single circulating number.

Why the primary measure is used as a biological marker

A core reason the study’s measurements function as meaningful biological markers is that the study treats vitamin D pathway components as mechanistic intermediates, not as associative correlates. Up-regulation of the vitamin D receptor and the vitamin D-1-hydroxylase gene in human macrophages is meaningful because, in the vitamin D system, receptor abundance and local activation capacity are direct determinants of whether cells can generate an intracellular ligand-receptor complex capable of driving transcription. In a signalling pathway, measuring the inducibility of the receptor and the activating enzyme is not a peripheral observation; it is measuring whether the cell has “built the machinery” needed for the pathway to operate.

Downstream, induction of an antimicrobial peptide (cathelicidin) is used as a functional marker because it is treated as an effector output of that induced programme. The study does not rely solely on one marker; it uses a logic chain where upstream pathway activation (receptor and hydroxylase gene induction) is connected to downstream transcriptional output and then linked to antimicrobial function. This layered approach matters for a system-level interpretation because it separates “presence of vitamin D metabolites” from “ability to execute vitamin D-mediated signalling,” and it places the emphasis on functional signalling sufficiency.

The study’s use of serum 25-hydroxyvitamin D status as a constraint is biologically meaningful because 25-hydroxyvitamin D is the predominant circulating pool that can act as a substrate for local conversion to 1,25-dihydroxyvitamin D within cells that express the activating enzyme. In an integrated endocrine-to-intracrine framework, serum 25-hydroxyvitamin D is not simply a marker of intake or sun exposure; it is the substrate reservoir that determines whether local conversion can produce enough intracellular ligand to activate transcription. Therefore, variability in serum 25-hydroxyvitamin D becomes meaningful in a mechanistic sense only because the study has already shown that the conversion machinery is induced and that the downstream effector is dependent on that pathway.

General physiological context (not derived from this study): vitamin D signalling operates across multiple layers of organisation. Endocrine signalling involves circulating metabolites produced or regulated in specific organs and delivered systemically; paracrine signalling involves local production and diffusion affecting nearby cells; intracrine signalling involves local production and action within the same cell. The same metabolite names can appear across these layers, but the physiological meaning changes depending on where activation occurs and which compartment is being measured. A study that demonstrates inducible local activation in human cells provides an entry point into that layered architecture because it shows how systemic pools can be requisitioned for local signalling tasks.

Study overview

At a high level, the study examines what happens in human macrophages when Toll-like receptors are activated, focusing specifically on whether that activation induces components of the vitamin D signalling pathway and whether that induction is functionally linked to antimicrobial responses. The investigators treated TLR activation as the initiating event and then traced downstream changes in gene expression relevant to vitamin D signalling, alongside changes in effector molecules and pathogen killing. This design is important because it makes the immune stimulus the upstream driver and tests whether vitamin D signalling becomes part of the macrophage response programme rather than treating vitamin D signalling as a static baseline state.

A notable feature of the approach is the use of serum conditions with differing 25-hydroxyvitamin D levels to test whether the ability to induce key downstream molecules varies in parallel with substrate sufficiency. This is not simply comparing populations for association; it is testing whether, under identical cellular triggers, the same signalling programme is partially disabled when endocrine substrate availability is lower. In an integrative physiology interpretation, this is where systemic endocrine pools become causally relevant to local cell-level pathway execution: the same local trigger is applied, but the outcome differs depending on the systemic substrate reservoir.

The study then links this pathway activation to antimicrobial activity, including responses against intracellular bacteria. While the pathogen context is specific, the physiological structure is general: an external trigger induces local activation capacity (intracrine capability), which draws on systemic pools (endocrine substrate), producing receptor-mediated transcription that leads to effector outputs. As a result, the study provides a concrete example of how endocrine and intracrine layers are not competing explanations but sequentially dependent components of one distributed signalling system that operates in tissue-specific contexts across the body.

Study design and measurement approach

The study design is best understood as a mechanistic pathway interrogation carried out in human innate immune cells under controlled stimulation. The investigators used Toll-like receptor activation of human macrophages as the initiating perturbation and then measured changes in expression of the vitamin D receptor and the vitamin D-1-hydroxylase gene, alongside downstream effector gene expression. This is a design where the primary interest is not a broad survey of correlates but a demonstration of induced pathway components that plausibly connect receptor triggering to functional outcome.

A key measurement principle is that the study does not rely on circulating measurements alone. Instead, it uses cellular gene expression markers as indicators of local pathway induction and couples those to functional readouts. This matters for interpreting endocrine versus intracrine roles because endocrine measurements alone cannot reveal whether the relevant conversion step is occurring within the responding tissue. By measuring inducible expression of the converting enzyme and receptor in the same cells that execute antimicrobial activity, the study makes a claim about local signalling capacity that is grounded in the measured cellular response.

The incorporation of serum from individuals with differing 25-hydroxyvitamin D levels functions as a controlled way to test substrate dependence without changing the initiating receptor signal. In other words, rather than comparing different stimuli across different people, the study holds the trigger constant and varies the support environment (serum substrate sufficiency). This is a critical method step for integration because it allows the study to test the dependency chain: local inducible conversion and receptor signalling may require sufficient systemic substrate availability, even when the initiating signal is not a vitamin D signal.

Temporal considerations are implicit in the design because induction of gene expression and subsequent effector outputs occur over time after stimulation. The study’s approach is therefore not a single snapshot correlation; it is an induced programme measured across a stimulus-response sequence. That sequence is central to interpreting the findings in a distributed signalling framework: the time ordering supports a model in which TLR activation precedes induction of vitamin D pathway machinery, which precedes effector induction and functional antimicrobial activity.

What the study can detect is a mechanistic chain operating within a specific tissue cell type: inducibility of the vitamin D receptor and activating enzyme within human macrophages; the dependency of downstream transcriptional responses on substrate availability in serum; and functional antimicrobial outcomes that track with activation of that induced programme. It can therefore detect whether a local signalling pathway is present, inducible, and functionally relevant in the responding cells, and whether systemic substrate availability acts as a limiting factor in executing that local programme.

What the study cannot detect is the full-body distribution of vitamin D metabolites across multiple organs, the relative quantitative contribution of renal endocrine production versus extrarenal production across the entire organism, or the long-term dynamics of tissue stores and release. It also cannot provide a general statement that the same integration architecture operates identically in all tissues; it provides a single, highly informative exemplar in a specific cellular context. The study’s strength is mechanistic specificity in one context, not comprehensive mapping of all signalling modes across all organs.

Outcome hierarchy

Directly measured outcomes
Induction of vitamin D receptor and vitamin D-1-hydroxylase gene expression in human macrophages following TLR activation; induction of antimicrobial peptide cathelicidin (mRNA); functional antimicrobial activity against intracellular bacteria; differential support of response by sera with differing 25-hydroxyvitamin D levels

Outcomes explicitly not measured
Systemic clinical outcomes; long-term infection incidence; whole-body vitamin D metabolite kinetics; multi-organ tissue concentrations of metabolites

Outcomes not inferable from this study
Population-level causality for disease risk; efficacy of any intervention; the relative dominance of endocrine versus intracrine signalling across all tissues; long-term storage mobilisation behaviour in the organism

Statistical analysis

The statistical analysis in this type of mechanistic study is generally oriented toward demonstrating reliable differences between experimental conditions (stimulated vs unstimulated; serum conditions that support vs do not support induction) and supporting the internal coherence of a causal chain rather than estimating population-level effect sizes. The evidence burden is therefore different from large cohort studies: the key question is whether the measured changes consistently track the experimental manipulation and whether the pattern is compatible with the proposed pathway sequence.

Because the study spans multiple layers of evidence (pathway component induction, effector induction, and functional antimicrobial activity), the strongest inferential value comes from pattern convergence. Where multiple outcomes shift in a coordinated direction under the same stimulus, and where changes are attenuated under substrate-limited conditions, the study’s interpretive force increases. The study’s statistical posture is therefore less about a single p-value and more about whether the set of measured endpoints align with the proposed mechanistic dependency chain.

Comparisons across sera with different 25-hydroxyvitamin D levels introduce an additional inferential dimension because they create a biologically meaningful gradient condition. The critical analytical question becomes whether the functional outcome (cathelicidin induction and killing) co-varies with substrate sufficiency under otherwise similar stimulation. If that alignment is observed, it supports a substrate-dependent mechanism rather than a nonspecific effect of serum differences.

Robustness considerations in a study of this type include whether findings persist across donors or replicates, whether the pathway induction is seen consistently after stimulation, and whether alternative explanations (such as general serum effects unrelated to vitamin D metabolites) are addressed by pathway-specific readouts. The interpretive weight is therefore carried by coherence, replication, and mechanistic specificity rather than by complex modelling designed for confounding control in observational population designs.

Results

The primary findings show that activation of Toll-like receptors in human macrophages induces the vitamin D signalling pathway at the level of pathway machinery: expression of the vitamin D receptor is increased, and expression of the vitamin D-1-hydroxylase gene is up-regulated. This result is foundational because it demonstrates that vitamin D signalling capacity in a responding tissue cell type is not merely constitutive; it can be induced as part of an innate immune activation programme. In an integrated signalling framework, this means that a non-vitamin D stimulus can actively recruit the vitamin D system, creating a context in which endocrine substrate pools become relevant to whether the recruited pathway can be executed.

Compartmental contrasts emerge when the study is interpreted across endocrine versus intracrine layers. The initiating trigger is a local receptor event at the cell surface, but the induced machinery implies a local conversion step that requires substrate. The endocrine compartment supplies circulating 25-hydroxyvitamin D, while the intracrine compartment uses induced hydroxylase activity to generate an intracellular ligand environment that can activate the induced receptor and drive transcription. The result is that endocrine and intracrine layers are not alternative explanations; they form an ordered dependency where endocrine availability conditions the ceiling of what the intracrine programme can achieve after induction.

A particularly instructive result is the observed relationship between sera that are low in 25-hydroxyvitamin D and reduced efficiency in supporting cathelicidin mRNA induction. This shifts the interpretation from “cells can do this” to “cells can do this only when substrate sufficiency exists.” In system terms, the local programme is inducible, but the endocrine pool sets a boundary condition for whether the local programme reaches its full effector output. This is precisely the kind of integrative result that clarifies why vitamin D biology cannot be fully understood in a single compartment: the meaningful physiological unit is the chain from circulating substrate to local conversion to receptor-mediated transcription to effector action.

The buffering and persistence implication in these findings is subtle but important. If local pathway activation depends on access to circulating substrate, then transient changes in endocrine substrate availability could translate into meaningful differences in local response capacity at the time a trigger occurs. That is distinct from long-term storage questions, but it demonstrates a form of functional buffering problem: a local tissue can be fully competent to respond, but the endocrine pool can still act as a limiting reagent in the moment the local programme is demanded. In integrated physiology, this implies that endocrine pools are not simply “background status”; they are part of the functional infrastructure enabling or constraining tissue-level intracrine programmes when those programmes are invoked.

Heterogeneity is visible in the study’s population-related observation: not all sera support the induced programme equally, and the difference aligns with 25-hydroxyvitamin D levels in the sera examined. While this is not a population epidemiology study, it still identifies a plausible axis of heterogeneity that maps onto the endocrine pool. That kind of heterogeneity is critical for a whole-body vitamin D interpretation because it suggests that local signalling competence cannot be assumed from the presence of the initiating trigger alone; the system’s capacity to execute a local programme varies with systemic substrate availability, and that variability can be expressed as differences in downstream effector induction and functional outcomes under otherwise similar stimulation conditions.

Measurement considerations and limitations

A major measurement consideration is that the study’s strongest claims are anchored to what it directly measures: inducible expression of the vitamin D receptor and vitamin D-1-hydroxylase genes in human macrophages after TLR activation, and downstream cathelicidin induction and antimicrobial activity. The integrity of the inference rests on the internal alignment of these measurements. The study’s design supports a pathway narrative because the induction of pathway machinery is measured in the same responding cells that show effector induction and antimicrobial function, but it still depends on the assumption that the measured gene expression changes correspond to functionally relevant pathway activation.

Another limitation is that serum conditions differ in many ways beyond 25-hydroxyvitamin D, and serum is a complex biological mixture. The study addresses this by tying the observed differences to a mechanistically coherent chain (substrate sufficiency enabling a local conversion-and-receptor programme), but the general limitation remains: any ex vivo serum-supported comparison can, in principle, be influenced by correlated factors. The strength here is that the outcomes measured are vitamin D pathway-relevant and the dependency is physiologically plausible; the weakness is that the study cannot completely isolate all correlated serum differences in the way that a pure biochemical reconstitution might.

The study also focuses on one cell type and one trigger paradigm. While macrophages are relevant for illustrating distributed signalling because they are peripheral tissue-resident immune cells that can respond rapidly to local stimuli, the results cannot be assumed to generalise identically to all tissues. The value for the physiology page is not that this describes all endocrine, paracrine, and intracrine vitamin D signalling everywhere; it is that it demonstrates a verified instance of systemic-to-local integration where endocrine substrate pools and local inducible conversion co-determine the ability to execute a receptor-mediated programme.

Without this study, the same biological scenario could be misread in at least two opposing ways. One misreading would be to treat declining or low serum 25-hydroxyvitamin D as irrelevant to local immune cell behaviour because the immediate trigger is a Toll-like receptor and not a vitamin D receptor. The other misreading would be to treat serum measures as fully explanatory, as though the presence of a circulating substrate automatically implies effective vitamin D action in tissues. This study corrects both errors by showing that local macrophage vitamin D signalling machinery is inducible as part of a trigger programme, and that executing that induced programme can still be constrained by systemic substrate availability. The correct reading is that serum measures alone are not “the action,” but they can be a limiting input into locally induced intracrine signalling in specific tissue contexts.

Generalisability and population context

The immediate generalisability of the findings applies most strongly to human monocytes and macrophages under innate immune stimulation contexts where Toll-like receptors are engaged and where the cell’s programme includes induction of vitamin D pathway components. The study provides evidence that, in humans, vitamin D receptor signalling is not simply a passive endocrine input but can be actively recruited as part of a local tissue response programme. That is a broadly relevant conceptual point even if the specific downstream effector (cathelicidin) is part of an immune context.

Population context enters through the observation that sera from individuals with lower 25-hydroxyvitamin D levels were less efficient in supporting cathelicidin induction in the experimental setting. The study does not claim a general population causal story for infection outcomes, but it does identify a physiologically meaningful source of variability: differences in the endocrine substrate pool can translate into differences in local response capacity in an inducible intracrine programme. This aligns with the broader vitamin D in-the-body architecture because it implies that systemic pools can function as enabling infrastructure for tissue-specific signalling programmes, and that population variation in systemic pools can express itself as variation in tissue response potential under relevant triggers.

The limits of generalisability are also clear. This study does not map signalling integration across multiple tissues, does not quantify the relative contributions of kidney-derived endocrine active metabolite versus local active metabolite generation across the body, and does not establish how often or in which tissues similar inducible programmes operate. It should therefore be treated as a validated case example of integration rather than as a complete model of the whole vitamin D system. Its value is to demonstrate the plausibility and biological reality of systemic-to-local dependency chains in human physiology.

Mechanistic inference boundary

The study supports a mechanistic inference that TLR activation can induce expression of vitamin D receptor and vitamin D-1-hydroxylase genes in human macrophages and that this induction is associated with downstream cathelicidin induction and antimicrobial activity. Within the measured system, it is reasonable to interpret that the vitamin D pathway is part of the induced antimicrobial programme. However, the inference boundary must remain tied to the measured chain: the study does not demonstrate that vitamin D signalling is the only pathway responsible for antimicrobial activity, nor does it quantify the exclusive contribution of each pathway component across all conditions.

A second boundary concerns compartmental interpretation. The study strongly motivates an integrated endocrine-to-intracrine interpretation, but it does not directly measure all metabolites in all compartments at all times. The endocrine component is represented primarily through the functional use of sera with differing 25-hydroxyvitamin D levels and the implication of substrate availability. The intracrine component is represented through induced expression of activation machinery and receptor. The study therefore supports the concept of a dependency chain, but it does not provide a full kinetic model of substrate uptake, intracellular conversion rates, or diffusion to neighbouring cells. Mechanistic integration here is best treated as an evidentiary-supported architecture rather than as a fully parameterised system.

Finally, while the study speaks to a local signalling programme, it should not be used to infer that the same inducible vitamin D programme will occur identically in all cell types, all tissues, or all immune contexts. The most defensible mechanistic claim is that human macrophages possess inducible vitamin D signalling machinery that can be engaged by innate immune receptor activation, and that systemic substrate availability can influence the magnitude of downstream effector induction in that context. Broader claims require additional study types and direct mapping across tissues and conditions.

This study does not justify treating any single blood measure as a complete proxy for “vitamin D action” in tissues, and it does not justify treating local signalling programmes as independent of systemic pools. It does not establish long-term outcomes, it does not demonstrate a universal rule that vitamin D status determines infection susceptibility in all contexts, and it does not provide a basis for clinical recommendations. It also does not prove that paracrine signalling to neighbouring cell types is occurring in vivo in this setting; while the induced pathway could have paracrine implications, the study’s direct evidence is strongest for an inducible intracellular programme within macrophages supported by systemic substrate availability. Any extension beyond these boundaries would exceed what the study directly measures.

Interpretation within vitamin D physiology

Within vitamin D physiology, the study is best interpreted as a verified demonstration of how endocrine, paracrine, and intracrine layers can be functionally coupled rather than compartmentalised into separate narratives. The endocrine layer appears as the systemic pool of 25-hydroxyvitamin D that can be drawn upon when cells induce activation machinery. The intracrine layer appears as the inducible local activation and receptor-mediated transcriptional response within the responding macrophage. The paracrine layer is not the primary measured focus, but the study’s architecture is compatible with the idea that locally generated active metabolite can have local neighbourhood effects; crucially, the study’s strongest contribution is to show that the meaningful physiological unit is the integrated chain from systemic substrate availability to local intracellular signalling capacity, rather than any single compartment readout.

For relevant physiology background, see Vitamin D in the Body.

Interpretation

The study’s primary interpretive contribution is to operationalise vitamin D signalling as a distributed, inducible system that can be recruited by external physiological triggers and that is constrained by systemic substrate availability. In the simplest endocrine-only framing, vitamin D would be a circulating hormone acting on target tissues; in a purely local framing, tissues would generate their own signals independently. This study supports neither extreme. Instead, it supports a coupled architecture where endocrine pools provide substrate and local tissues can inducibly convert and respond, meaning that systemic status and local signalling capacity are jointly necessary for full pathway execution in specific contexts.

A second interpretive layer is that “vitamin D in the body” should be thought of as infrastructure, not only as a signal. The endocrine pool of 25-hydroxyvitamin D becomes biologically meaningful in this study not because the pool itself is the effector, but because the pool determines whether induced local activation can supply enough ligand to drive receptor-mediated transcription. In that sense, vitamin D metabolites function as a resource that tissues can draw upon when the appropriate inducible programme is activated. This is a whole-body concept: a circulating reservoir can be requisitioned locally, and local physiology determines whether and how that reservoir is converted into a signalling event.

A further interpretive implication is that apparent contradictions between serum status and tissue function are not necessarily contradictions at all, but consequences of a multi-step dependency chain. A serum pool can be present yet functionally irrelevant in a tissue that cannot induce activation; a tissue can be fully competent yet limited by an insufficient circulating substrate pool; and both states can coexist across different tissues because activation machinery and receptor signalling contexts differ. This study does not resolve all such complexity, but it provides an evidentiary anchor for why those complexities are expected in a distributed signalling system and why integration across endocrine and intracrine layers is necessary for accurate physiological interpretation.

To extend what this study establishes into a broader integration map, future study types would need to include compartment-aware tracer studies that quantify uptake of circulating 25-hydroxyvitamin D into tissues and its conversion to active metabolites under defined triggers; longitudinal studies of inducible conversion capacity across different tissues and physiological states; and direct coupling of systemic transport and binding protein dynamics to tissue-level activation outcomes. In addition, studies that directly compare multiple tissues in the same organism under the same endocrine substrate conditions would be required to distinguish which tissues primarily act as endocrine responders versus which tissues frequently employ inducible intracrine programmes. These study types would move the field from a verified exemplar of integration to a comprehensive system-level atlas of endocrine, paracrine, and intracrine vitamin D signalling across the body.

Primary source and publication details

Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al.

Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response

Science. 2006.

DOI: 10.1126/science.1123933

Primary source

Related reading

Original sources